Gordon, Louisa G. http://orcid.org/0000-0002-3159-4249
Wood, C.
Tothill, R. W.
Webb, P. M.
Schofield, P.
Mileshkin, L.
,
Funding for this research was provided by:
Cancer Australia (1048193, 1082604)
Victorian Cancer Agency (13062-1413768)
Article History
Accepted: 25 August 2022
First Online: 17 October 2022
Declarations
:
: This study was supported by grants from Cancer Australia No: 1048193 (2013–2016) and 1082604 (2015–2018) and Victorian Cancer Agency No: 13062-1413768 (2014–2017).
: Authors LGG, PS, RWT, LM and CW declare that they have no conflict of interest. Author PMW has received grant funding from AstraZeneca for an unrelated study of ovarian cancer and a speaker’s fee from AstraZeneca.
: Ethical approval for this economic sub-study was waived by the QIMR Berghofer Human Ethics Research Committee P3609. The clinical CUP study was approved by the Peter MacCallum Cancer Centre Human Ethics Research Committee and all participating sites.
: Participants were informed about the aim of the study, and participant consent was required to start data collection, including separate consent to obtain Medicare data from Services Australia, the Australian Government.
: Participants were informed about the aim of this study, including the intent to publish findings, and participant consent was required to start the data collection.
: The data used in this study are unable to be shared under the approval provided by data custodians of Services Australia under a Commonwealth of Australia contract.
: The data analysis code written in STATA is available from the authors upon request
: LGG performed the statistical modelling and data analysis and produced the first written draft of the paper. All authors contributed to conceptualisation, data analysis interpretation, writing and editing. LM and RWT provided clinical expertise, knowledge and intellectual inputs and obtained grants and conducted data collection. CW contributed to data cleaning and management. All authors were involved in writing and editing and approved the final version.